Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2000 | 1 |
2002 | 1 |
2006 | 1 |
2023 | 0 |
Search Results
3
results
Results by year
Page 1
Efficacy of a motilin receptor agonist (ABT-229) for the treatment of gastro-oesophageal reflux disease.
Aliment Pharmacol Ther. 2002 Apr;16(4):749-57. doi: 10.1046/j.1365-2036.2002.01218.x.
Aliment Pharmacol Ther. 2002.
PMID: 11929393
Free article.
Clinical Trial.
ABT-089, a neuronal nicotinic receptor partial agonist, for the treatment of attention-deficit/hyperactivity disorder in adults: results of a pilot study.
Wilens TE, Verlinden MH, Adler LA, Wozniak PJ, West SA.
Wilens TE, et al. Among authors: verlinden mh.
Biol Psychiatry. 2006 Jun 1;59(11):1065-70. doi: 10.1016/j.biopsych.2005.10.029. Epub 2006 Feb 23.
Biol Psychiatry. 2006.
PMID: 16499880
Clinical Trial.
Item in Clipboard
Effect of novel motilide ABT-229 versus erythromycin and cisapride on gastric emptying in dogs.
Cowles VE, Nellans HN, Seifert TR, Besecke LM, Segreti JA, Mohning KM, Faghih R, Verlinden MH, Wegner CD.
Cowles VE, et al. Among authors: verlinden mh.
J Pharmacol Exp Ther. 2000 Jun;293(3):1106-11.
J Pharmacol Exp Ther. 2000.
PMID: 10869416
Item in Clipboard
Cite
Cite